1,092
Views
0
CrossRef citations to date
0
Altmetric
Brief Report

Design, synthesis, biological evaluation and molecular docking study of 2,4-diarylimidazoles and 2,4-bis(benzyloxy)-5-arylpyrimidines as novel HSP90 N-terminal inhibitors

, , , , , , & ORCID Icon show all
Pages 2551-2565 | Received 24 Jun 2022, Accepted 09 Sep 2022, Published online: 19 Sep 2022